checkAd

     124  0 Kommentare ADMA Biologics Receives Unique Permanent J-Code for ASCENIV - Seite 3

    COMPANY CONTACT:
    Skyler Bloom
    Director, Investor Relations and Corporate Strategy | 201-478-5552 | sbloom@admabio.com

    Lesen Sie auch

    INVESTOR RELATIONS CONTACT:
    Sam Martin
    Managing Director, Argot Partners | 212-600-1902 | sam@argotpartners.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    ADMA Biologics Receives Unique Permanent J-Code for ASCENIV - Seite 3 RAMSEY, N.J. and BOCA RATON, Fla., Jan. 26, 2021 (GLOBE NEWSWIRE) - ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, …